These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32910478)

  • 1. Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer.
    Duska LR; Scalici JM; Temkin SM; Schwarz JK; Crane EK; Moxley KM; Hamilton CA; Wethington SL; Petroni GR; Varhegyi NE; Clift SH; Bullock TNJ; Showalter TN
    Cancer; 2020 Nov; 126(22):4948-4956. PubMed ID: 32910478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502).
    Weickhardt A; Foroudi F; Lawrentschuk N; Xie J; Sidhom M; Pal A; Grimison P; Zhang A; Ng S; Tang C; Hovey E; Chen C; Hruby G; Guminski A; McJannett M; Conduit C; Tran B; Davis ID; Hayne D
    Eur Urol Oncol; 2024 Jun; 7(3):469-477. PubMed ID: 37806844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial.
    da Costa SCS; Bonadio RC; Gabrielli FCG; Aranha AS; Dias Genta MLN; Miranda VC; de Freitas D; Abdo Filho E; Ferreira PAO; Machado KK; Scaranti M; Carvalho HA; Estevez-Diz MDP
    J Clin Oncol; 2019 Nov; 37(33):3124-3131. PubMed ID: 31449470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lorusso D; Xiang Y; Hasegawa K; Scambia G; Leiva M; Ramos-Elias P; Acevedo A; Cvek J; Randall L; Pereira de Santana Gomes AJ; Contreras Mejía F; Helpman L; Akıllı H; Lee JY; Saevets V; Zagouri F; Gilbert L; Sehouli J; Tharavichitkul E; Lindemann K; Colombo N; Chang CL; Bednarikova M; Zhu H; Oaknin A; Christiaens M; Petru E; Usami T; Liu P; Yamada K; Toker S; Keefe SM; Pignata S; Duska LR;
    Lancet; 2024 Oct; 404(10460):1321-1332. PubMed ID: 39288779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer.
    Mayadev J; Zamarin D; Deng W; Lankes H; O'Cearbhaill R; Aghajanian CA; Schilder R
    Int J Gynecol Cancer; 2020 May; 30(5):701-704. PubMed ID: 31871115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study.
    Gandhi AK; Sharma DN; Rath GK; Julka PK; Subramani V; Sharma S; Manigandan D; Laviraj MA; Kumar S; Thulkar S
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):542-8. PubMed ID: 24074927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer.
    Garcia-Soto AE; McKenzie ND; Whicker ME; Pearson JM; Jimenez EA; Portelance L; Hu JJ; Lucci JA; Qureshi R; Kossenkov A; Schwartz L; Mills GB; Maity A; Lin LL; Simpkins F
    Cancer; 2021 Jul; 127(13):2279-2293. PubMed ID: 33932031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.
    Lorusso D; Xiang Y; Hasegawa K; Scambia G; Leiva M; Ramos-Elias P; Acevedo A; Sukhin V; Cloven N; Pereira de Santana Gomes AJ; Contreras Mejía F; Reiss A; Ayhan A; Lee JY; Saevets V; Zagouri F; Gilbert L; Sehouli J; Tharavichitkul E; Lindemann K; Lazzari R; Chang CL; Lampé R; Zhu H; Oaknin A; Christiaens M; Polterauer S; Usami T; Li K; Yamada K; Toker S; Keefe SM; Pignata S; Duska LR;
    Lancet; 2024 Apr; 403(10434):1341-1350. PubMed ID: 38521086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 1 Trial of Concurrent Gemcitabine and Cisplatin with Image Guided Intensity Modulated Radiation Therapy for Locoregionally Advanced Cervical Carcinoma.
    Mell LK; Xu R; Yashar CM; McHale MT; Einck JP; Mayadev J; Lee E; Binder P; Rash D; Eskander R; Heide ES; Plaxe SC; Mundt AJ; Saenz CC
    Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):964-973. PubMed ID: 32334034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended-field radiotherapy for locally advanced cervical cancer.
    Thamronganantasakul K; Supakalin N; Kietpeerakool C; Pattanittum P; Lumbiganon P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012301. PubMed ID: 30362204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image Guidance Volume-Modulated Arc Radiation Therapy Concurrently With Nab-Paclitaxel Plus Cisplatin for Patients With Locally Advanced Cervical Cancer: A Single-Arm Dose Escalation Trial.
    Jiang P; Deng X; Qu A; Jiang W; Guo F; Han Q; Guo H; Wang J
    Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1197-1204. PubMed ID: 36402358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of bevacizumab in combination with definitive radiotherapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma: preliminary results of RTOG 0417.
    Schefter TE; Winter K; Kwon JS; Stuhr K; Balaraj K; Yaremko BP; Small W; Gaffney DK
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1179-84. PubMed ID: 22342094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study.
    Powell SF; Gold KA; Gitau MM; Sumey CJ; Lohr MM; McGraw SC; Nowak RK; Jensen AW; Blanchard MJ; Fischer CD; Bykowski J; Ellison CA; Black LJ; Thompson PA; Callejas-Valera JL; Lee JH; Cohen EEW; Spanos WC
    J Clin Oncol; 2020 Jul; 38(21):2427-2437. PubMed ID: 32479189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study.
    Lakhani NJ; Chow LQM; Gainor JF; LoRusso P; Lee KW; Chung HC; Lee J; Bang YJ; Hodi FS; Kim WS; Santana-Davila R; Fanning P; Squifflet P; Jin F; Kuo TC; Wan HI; Pons J; Randolph SS; Messersmith WA
    Lancet Oncol; 2021 Dec; 22(12):1740-1751. PubMed ID: 34793719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer.
    Tangjitgamol S; Katanyoo K; Laopaiboon M; Lumbiganon P; Manusirivithaya S; Supawattanabodee B
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010401. PubMed ID: 25470408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: The PROLUNG Phase 2 Randomized Clinical Trial.
    Arrieta O; Barrón F; Ramírez-Tirado LA; Zatarain-Barrón ZL; Cardona AF; Díaz-García D; Yamamoto Ramos M; Mota-Vega B; Carmona A; Peralta Álvarez MP; Bautista Y; Aldaco F; Gerson R; Rolfo C; Rosell R
    JAMA Oncol; 2020 Jun; 6(6):856-864. PubMed ID: 32271354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial.
    Youn JW; Hur SY; Woo JW; Kim YM; Lim MC; Park SY; Seo SS; No JH; Kim BG; Lee JK; Shin SJ; Kim K; Chaney MF; Choi YJ; Suh YS; Park JS; Sung YC
    Lancet Oncol; 2020 Dec; 21(12):1653-1660. PubMed ID: 33271094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial.
    Jabbour SK; Berman AT; Decker RH; Lin Y; Feigenberg SJ; Gettinger SN; Aggarwal C; Langer CJ; Simone CB; Bradley JD; Aisner J; Malhotra J
    JAMA Oncol; 2020 Jun; 6(6):848-855. PubMed ID: 32077891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy in locally advanced cervical cancer: Integrating KEYNOTE-A18 into management strategies.
    How JA; Jazaeri AA
    Med; 2024 Jun; 5(6):487-489. PubMed ID: 38878765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life of locally advanced cervical cancer patients after neoadjuvant chemotherapy followed by chemoradiation versus chemoradiation alone (CIRCE trial): a randomized phase II trial.
    Nunes de Arruda F; da Costa S; Bonadio R; Dornellas A; Pereira D; de Bock GH; Del Pilar Estevez Diz M
    Int J Gynecol Cancer; 2020 Jun; 30(6):749-756. PubMed ID: 32321767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.